{"id":"yellox","rwe":[],"tags":[],"safety":{"commonSideEffects":[{"effect":"Abnormal sensation in eye","drugRate":"6.1%","severity":"common"},{"effect":"Conjunctival hyperemia","drugRate":"6.1%","severity":"common"},{"effect":"Eye irritation","drugRate":"6.1%","severity":"common"},{"effect":"Eye pain","drugRate":"reported","severity":"unknown"},{"effect":"Eye pruritus","drugRate":"reported","severity":"unknown"},{"effect":"Eye redness","drugRate":"reported","severity":"unknown"},{"effect":"Headache","drugRate":"reported","severity":"unknown"},{"effect":"Iritis","drugRate":"reported","severity":"unknown"}],"contraindications":["Diabetes mellitus","Epithelial Keratopathy","Red eye","Rheumatoid arthritis"]},"trials":[],"_chembl":null,"aliases":["Bromfenac 0.09 % Ophthalmic Solution"],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T11:50:13.557328","offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Cyclooxygenase","modality":"Small Molecule"},"_scrapedAt":"2026-03-28T01:41:16.241Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:38:42.925926+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Pain","diseaseId":"pain","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Post-Op Ocular Inflammation","diseaseId":"post-op-ocular-inflammation","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Postoperative Ocular Pain","diseaseId":"postoperative-ocular-pain","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["sideEffects","modality→Small Molecule"],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03317847","phase":"PHASE4","title":"Bromfenac Versus Dexamethasone After Cataract Surgery","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2017-10-16","conditions":"Inflammation Eye","enrollment":92},{"nctId":"NCT02137161","phase":"PHASE4","title":"Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2013-11","conditions":"Cataract, Pseudoexfoliation Syndrome","enrollment":62},{"nctId":"NCT05158699","phase":"PHASE3","title":"Effectiveness of Periocular Drug Injection in CATaract Surgery","status":"TERMINATED","sponsor":"Luigi Rondas","startDate":"2021-10-13","conditions":"Macular Edema, Cystoid Macular Edema, Retinal Disease","enrollment":628},{"nctId":"NCT03597867","phase":"PHASE3","title":"PGE2 Levels in Patient Treated With NSAIDs","status":"COMPLETED","sponsor":"University of Trieste","startDate":"2018-04-25","conditions":"Ocular Inflammation","enrollment":104},{"nctId":"NCT01774474","phase":"PHASE3","title":"PRevention of Macular EDema After Cataract Surgery","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2013-07-10","conditions":"Cystoid Macular Edema, Cataract, Diabetes Mellitus","enrollment":1127}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL3181947","pubchemSID":"104102824"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Pain"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_3","status":"active","brandName":"Yellox","genericName":"Yellox","companyName":"University of Trieste","companyId":"university-of-trieste","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Yellox is a brand name for bromfenac, a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of ocular inflammation and pain. It is a small molecule cyclooxygenase inhibitor, marketed for short-term, local use in the treatment of various eye conditions, including macular edema, cystoid macular edema, and cataract.","enrichmentLevel":5,"visitCount":0,"trialStats":{"total":4,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:38:42.925926+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}